(Q34694845)

4 August 2017

title

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer (English)

1 reference

4 August 2017

9

Paul D P Pharoah

1 reference

4 August 2017

Emad Rakha

2

0 references

Andrew Green

object named as

Andrew Green

3

0 references

Ian Ellis

object named as

Ian Ellis

4

0 references

Carlos Caldas

8

object named as

Carlos Caldas

1 reference

4 August 2017

7

Fiona M Blows

1 reference

4 August 2017

Gordon C Wishart

1

1 reference

4 August 2017

Hamid Raza Ali

5

1 reference

4 August 2017

Elena Provenzano

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

3 December 2014

1 reference

4 August 2017

1 reference

4 August 2017

volume

14

1 reference

4 August 2017

page(s)

908

1 reference

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Ki67 and proliferation in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Ki67 in breast cancer: prognostic and predictive potential

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Supervised risk predictor of breast cancer based on intrinsic subtypes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

A gene-expression signature as a predictor of survival in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Molecular portraits of human breast tumours

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265394

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-14-908

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-14-908

The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25472026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A population-based validation of the prognostic model PREDICT for early breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25472026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-14-908

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference